Participants List
 (Academia)

Ain-Shams University, Egypt

Akershus University Hospital, Norway

Albany Medical College, USA

Albert Eintein College of Medicine, Beth Israel Medicine, USA

Altai State Technical University, Russia

American Heart Association, USA

Antwerp University Hospital, Antwerp, Belgium

Ariel University Center In Samaria, Israel

Ariel University Center of Samaria, Israel

Aristotle University of Thessaloniki, Greece

Athens Medical School, Greece

Baylor College of Medicine, USA

Biological Sciences Federal UniversityBrazil.

Bournemouth Diabetes and Endocrine Centre, UK

Buck Institute for Age Research, USA

Cardiff School of Biosciences, UK

Carleton University, Canada

Center for Advancement of Drug Research and Evaluation (CADRE), USA

Centre Cardiologique du Nord, France

Centre de Recherche des Cordeliers France

Chang-Gung Memorial Hospital, Taiwan

Charles University, Czech Republic

Chiba University Graduate School of Medicine, Japan

China Medical University, Taiwan

Chinese Academy of Sciences, China

Christian Medical College, India

Chubu University, Japan

Chung-Ang University, Korea

D. Cotugno Hospital, Italy

David Geffen School of Medicine at UCLA, USA

Deakin University, Australia

Deakin University, Australia

Docenti Unina University, Italy

East Carolina University, USA

Ege University, Turkey

Emory University School of Medicine, USA

ERS, ATS, Geneva, Switzerland

European Medicines Agency (EMEA), UK

Fernando Pessoa University, Portugal

German Research School for Simulation Sciences GmbH, Germany

Goethe University Frankfurt, Germany

Government Of India, India

Graduate School of Medical Sciences Cornell University, USA   

Harvard Medical School, USA

Helsinki University Central Hospital, Finland

Hong Kong University, China

Hungarian Academy of Sciences, Hungary

Ibaraki. University, Japan

IIT Madras, India

Illinois College of Medicine, USA

Imperial College Kidney and Transplant Institute, UK

Imperial College London, UK

Indiana University Melvin and Bren Simon Cancer Center, USA

Institut Charles Gerhardt UMR 5253, MACS Team, France

Institute for Biological Sciences, National Research Council of Canada, Canada

Institute for Molecular Science, Japan

Institute of Biomedical Chemistry (IBMC RAMS), Russia

Institute of Physiologically Active Compounds, Russia

Institute of PLA of Chinese Medicine, China

International University of Health and Welfare Graduate School, Japan

IRCCS Neuromed, Italy

IRCM. Inserm U896, CRLC Val d'Aurelle-Parc Euromdecine, France

Jackson State University, USA

Jackson State University, USA

Janssen Pharmaceutica N.V., Belgium

Janssen Pharmaceutica N.V., Belgium

Johns Hopkins University School of Medicine, USA

Juntendo University Urayasu Hospital, Japan

King Abdulaziz University, Kingdom of Saudi Arabia

King's College London, UK

Korea University, Korea

Kursk State Technical University, Russian

Lake Erie College of Osteopathic Medicine, USA

Lake Erie College of Osteopathic Medicine, USA

Laval University, Canada

Leiden University Medical Center, The Netherlands

Lincoln's Inn Fields Laboratories, UK

Linnaeus University, Sweden

Loyola University Medical Center. USA

Lund University, Sweden

Lundbeck Research USA, USA

Max Planck Institute for Biophysical Chemistry, Germany

McGill University, Canada

McGill University, Meakins-Christie Laboratories, Canada

McMaster University, Canada

Medical College of Georgia, USA

Medical University of Lodz, Poland

Medical University of South Carolina, USA

Medical University of South Carolina, USA

Medical University of Vienna (MUV), Austria

Memorial Sloan-Kettering Cancer Center, USA

Merck In-Licensing, China

Microbiology Sapienza University of Rome, Italy

Monash University, Australia

Moores UCSD Cancer Center, USA

Moscow State University (MSU), Russia

N.N.Voroztsov Institute of Organic Chemistry SB RAS, Russia

N.N.Voroztsov Institute of Organic Chemistry SB RAS, Russia

Nanyang Technological University, Singapore

National Institute of Chemistry, Slovenia

National Research Council (CNR), Italy

New York State Psychiatric Institute, USA

New York-Presbyterian Hospital/Columbia University Medical Center, USA

Northeast Agriculture University, China

Novartis Institutes for BioMedical Research, USA

NYU School of Medicine, USA.

Oncology Roswell Park Cancer Institute Buffalo, USA

Oregon Health & Science University, USA

Osaka Prefecture University, Japan

Paediatric Oncology Research, Medico-surgical Paediatric Department (DMCP), Switzerland

Pfizer, USA

Physiology-Pharmacology and environmental Health Laboratory, Morocco

Pierre and Marie Curie University, France

Polish Academy of Sciences, Poland

Pontifical Catholic University of Rio Grande do Sul, Brazil

Psychiatry UMKC School of Medicine, USA

Queen's University, UK

Radboud University, The Netherlands

Rashtrasant Tukadoji Maharaj Nagpur University, India

Research Unit PASTEUR, France

Research Unit for Biomedical Informatics, Spain

Roche R&D China, China

Shanxi Medical University, China

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Russia

Shujitsu University School of Pharmacy, Japan

SloanCKettering Institute for Cancer, USA

Soochow University, China

Southern Alberta Cancer Research Institute, Canada

Stanford University, USA

Stony Brook University, USA

Sub Dean International, Faculty of Science, Australia

Sungkyunkwan University School of Medicine, South Korea    

Sunnybrook Health Sciences Centre, Canada

Tel Aviv University, Israel

Terry Fox Laboratory, BC Cancer Research Center, Canada

The Angeles Clinic and Research Institute, USA

The George Washington University Medical Faculty Associates., USA

The University of Texas Health Science Center at Tyler, USA

The University of Tokyo, Japan

Tianjin Medical University

TNO BioSciences, The Netherlands

Tokushima Bunri University, Japan

Tongji Medical college, China

Translational Medicine Research Centre, MSD, Singapore

Tsinghua University, China

Tufts Medical Center, USA

Turku University, Finland

UCDavis School of Medicine, USA

Universidad de Buenos Aires, Argentina

University College London, UK

University Hospital Basel, Switzerland

University Hospital of Iceland, Iceland

University of Basel, Switzerland

University of Basilicata, Italy

University of Bayreuth, Germany

University of Berne, Switzerland

University of Birmingham, UK

University of Bologna, Italy

University of Bologna, Italy

University of Cagliari, Italy

University of Cologne, Germany

University of Colorado Denver Anschutz Medical Campus, USA

University of Colorado Denver, USA

University of Copenhagen, Denmark

University of Debrecen, Hungary

University of Dundee, UK

University of Edinburgh, ISB, School of Biological Sciences, UK

University of Florida, USA

University of G?ttingen Medical School, Germany

University of Granada, Spain

University of Hyderabad, India

University of Leicester, UK

University of Liverpool, UK

University of Louisville in Louisville, USA

University of Manitoba, Canada

University of Massachusetts Medical School, USA

University of Medicine & Dentistry of New Jersey and VA Medical Center, USA

University of Miami Medical School, USA

University of Milan, Italy

University of Minnesota Medical School, USA

University of Minnesota, USA

University of Missouri-Columbia School of MedicineUSA

University of Miyazaki, Japan

University of Nice Sophia Antipolis, France

University of Nice Sophia Antipolis, France

University of Oxford, Uk

University of Oxford, UK

University of Pennsylvania, USA

University of Pittsburgh School of Medicine, USA

University of Pittsburgh School of Medicine, USA

University of Rio de Janeiro Medical School, Brazilian Brain Institute, Brazil

University of Rome "Tor Vergata", Italy

University of Science & Technology in Korea, Korea

University of Sherbrooke, Canada

University of Sherbrooke, Canada

University of South Alabama, USA

University of Southern Nevada College of Pharmacy, USA

University of Strasbourg, France

University of Tasmania, Australia

University of Tasmania, Australia

University of Tennessee College of Veterinary Medicine, USA

University of Texas Houston Medical School, USA

University of the Incarnate Word, USA

University of Udine, Italy

University of Western Sydney, Australia

University of Wisconsin School of Medicine and Public Health, USA

University of Wisconsin-Milwaukee, USA

University of Wisconsin-Whitewater, USA

University of Munich, Germany

Uppsala University, Sweden

USA Mitchell Cancer Institute, USA

UT Southwestern Medical Center, USA

Victoria University, Australia

Virginia Commonwealth University, USA

VIT University, India

Weill Cornell Medical College in Qatar, Qatar

Weill Cornell Medical College, USA

Weill Medical College of Cornell University, USA

Wroclaw Medical University, Poland

Yale University School of Medicine, USA

Menoufyia University, Egypt



 Participants List
 (Business)

A*STAR, Singapore

Abbott Park, USA

Addex Pharmaceuticals, Switzerland

?terna Zentaris, Germany

Agilent Technologies, USA

Alacrita LLP, UK

AstraZeneca Pharmaceuticals LP, USA

AstraZeneca KK, Japan

Avanti Group of Companies, USA

Banyan Biomarkers, Inc., USA

Beth Israel Deaconess Medical Center, USA

Biocept, Inc., USA

BiogenIdec Inc. USA

Boehringer Ingelheim Pharma GmbH & Co. KG, Germany

Boehringer Ingelheim Pharmaceuticals, Inc., USA

Boehringer Ingelheim Pharmaceuticals, USA

Bridge Laboratories, China

Bristol Myers Squibb, USA

Bristol-Myers Squibb Co., USA

Caerus Consulting Pty. Ltd, Australia

Caprotec Bioanalytics GmbH, Germany

Cellx Inc., USA

Charite Virchow Klinikum, Germany.

Chemizon, Inc., China

Chrysalis Pharma Consulting, LLC, USA

Cisbio Bioassays, France

Close Concerns, Inc., USA

CodexBiosolutions, USA

Collegium Internationale Neuro-Psychopharmacologicum (CINP), Sweden

Crown BioScience, Inc., USA

Daiichi Sankyo Pharma Development, USA

Dr. Behçet Uz Children's Hospital, Turkey

Dr. Siyami Ersek Hospital, Turkey

Eli Lilly and Company, USA

Environmental Health Foundation, USA

European ScreeningPort GmbH, Germany

F. Hoffmann-La Roche Ltd, Switzerland

Foley & Lardner LLP, USA

Freeman Hospital, UK

Fulford India Ltd(Subsidiary of Schering Plough Corporation USA), India

Genentech, Inc., USA

GlaxoSmithKline Pharmaceuticals, UK

GlaxoSmithKline, USA

Hamamatsu Photonics K.K., Japan

Health and Human Services, USA

Hirslanden Private Hospital Group, Switzerland

Hoffmann-La Roche Inc., USA

HoffmannCLa Roche Inc., USA

Hospital for Special Surgery, USA

Hospital Geral, Goiania, Brazil

Hospital Henri Mondor, France

IHMA Europe Sarl, Switzerland

Inamed Research GmbH & Co., Germany

ITHW, Inc., USA

Johnson and Johnson Pharmaceuticals, Belgium

Kaiser Oakland Medical Center, USA

KEM Hospital, India

Mayo Clinic, USA

McLean Hospital, USA

Medication Delivery--Baxter Healthcare, USA

Merck & Co., USA

Monogram Biosciences, Inc., USA

Musgrove Park Hospital, UK

NeuroProof GmbH, Germany

New York Harbor HCS, USA

Novalead Pharma Pvt. Ltd., India

Novartis Pharma AG, Switzerland

Novartis, USA

ObeTherapy, France

Octagon Research Solutions, USA

Oramed Pharmaceutical Inc., USA

Orion Pharma, Finland

Paracelsus-Hospital, Germany

Pfizer (China) R&D, China

Pfizer Global Research and Development, UK

Philip Morris Research Laboratories GmbH, Germany

Primus Pharmaceuticals, Inc., USA

Profil Institute for Clinical Research Inc., USA

Ramot at Tel Aviv University Ltd., Israel

Ranbaxy Laboratories Ltd., India

Real Data Medical Research Inc., China

Roche Pharma Partnering, USA

Rosetta Genomics, USA

S & P, Biotech & Pharma Investment, USA

S*BIO Pte Ltd., Singapore

San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera, Italy

Sanofi-Pasteur, Canada

Santaris pharma a/s, RNA Medicines for the 21st Century, Danmark

Schering Plough Corporation, The Netherlands

Somagenics, Inc., USA

Sovicell GmbH, Germany

St. Jude Childrens Research Hospital, USA

St. Luke's Episcopal Hospital, USA

Supercomputing Center (BSC), Spain

Threshold Pharmaceuticals Inc., USA

Threshold Pharmaceuticals Inc., USA

TWI Pharma, Taiwan

Vastrata Ltd, UK

Westmead Hospital, Australia

Wyeth Research, USA

 



 
 Schedule


Program Schedule
Time: October 23-26, 2010
Place: Beijing International Convention Center (BICC), China
Beijing Continental Grand Hotel (BCGH), China

Date

Time

Activities

Venue

October 22, 2010
(Friday)

08:00-20:00

Registration

3rd Floor, BICC

October 23, 2010
(Saturday Morning)

08:20-08:40

Group Photo

Outside Square, BICC

09:00-11:20

Opening Ceremony & Keynote Lectures

Room No. 2, 2nd Floor, BICC

October 23, 2010
(Saturday Afternoon)

13:30-17:35

Section 1-1: Oncology and Drug Discovery (Part I)

Room No. 301, 3rd Floor, BICC

13:30-14:45

Section 2-1: Genomics, Proteomics and Metabolomics in Drug Discovery and Target Validation

Room No. 203B, 3rd Floor, BICC

13:30-16:45

Section 2-2: Advancing Molecular Target Discovery and Drug Screening

Room No. 305C, 3rd Floor, BICC

15:30-18:00

Section 2-3: Biomarkers for Drug Discovery

Room No. 203B, 3rd Floor, BICC

15:30-18:00

Section 3-1-1: Novel Target and Biomarker of Cardiovascular Diseases

Room No. 203A, 3rd Floor, BICC

13:30-17:10

Section 3-2-1: Drug Discovery Targeting Alzheimer' s Disease (Part I)

Room No. 302, 3rd Floor, BICC

13:30-15:10

Section 3-2-2: Drug Discovery Targeting Parkinson' s Disease

Room No. 203A, 3rd Floor, BICC

13:30-16:45

Section 3-4-1: Drug Discovery Targeting Asthma and Chronic Obstructive Pulmonary Disease (COPD)

Room No. 303, 3rd Floor, BICC

13:30-16:45

Section 3-4-2: Anti-Inflammatory Drugs

Room No. 310, 3rd Floor, BICC

13:30-14:45

Section 3-7-1: Challenges and Opportunities

Room No. 311A, 3rd Floor, BICC

15:30-17:10

Section 3-7-2: Antibacterial Drug Resistance Drug Discovery

Room No. 311A, 3rd Floor, BICC

13:30-16:45

Section 3-8: MDR/XDR-TB and Malaria Drug Discovery

Room No. 308, 3rd Floor, BICC

13:30-16:45

Section 4-1: Receptors and Ion Channel Based Drug Design and Medicinal Chemistry

Room No. 311B, 3rd Floor, BICC

13:30-17:35

Section 5-1: Innovations and Improvement of Major Biotherapeutics

Room No. 311C, 3rd Floor, BICC

13:30-16:45

Section 6-1: New Formulation and Drug Delivery System Development

Room No. 306, 3rd Floor, BICC

13:30-17:35

Section 7-1: Scientific Revisit of Major TCM Combinatorial Formulations

Room No. 312, 3rd Floor, BICC

13:30-15:10

Section 8-1: Translational Medicine and Globalization Strategies (Part I)

Room No. 307, 3rd Floor, BICC

15:30-17:30

Section 8-2: Translational Medicine and Globalization Strategies (Part II)

Room No. 307, 3rd Floor, BICC

18:30-20:30

Welcome Banquet and Art Performance

Hotel Garden, BCGH

October 24, 2010
(Sunday Morning)

08:30-10:55

Section 1-2: Endocrinology and Drug Discovery

Room No. 305A, 3rd Floor, BICC

08:30-11:20

Section 1-3: Personalized Medicine and Drug Discovery

Room No. 305B, 3rd Floor, BICC

08:30-11:45

Section 2-4: Bioinformatics/Chemoinformatics and Bio-IT/Pharm-IT for Drug Discovery

Room No. 305C, 3rd Floor, BICC

08:30-12:10

Section 2-8: HPLC/GC, LC/GC-MS, Maldi-TOF and Structure Biology for Drug Discovery (Part I)

Room No. 301, 3rd Floor, BICC

08:30-09:45

Section 3-2-3: Drug Discovery Targeting Alzheimer's Disease (Part II)

Room No. 302, 3rd Floor, BICC

10:30-11:45

Section 3-2-4: Drug Discovery Targeting Amyotrophic Lateral Sclerosis

Room No. 302, 3rd Floor, BICC

08:30-11:45

Section 3-5: Mental Disease Drug Discovery

Room No. 303, 3rd Floor, BICC

10:55-12:10

Session 3-7-3: Antifungal and Antiviral Drug Discovery

Room No. 305A, 3rd Floor, BICC

October 24, 2010
(Sunday Afternoon)

13:30-17:35

Section 1-1: Oncology and Drug Discovery (Part II)

Room No. 305C, 3rd Floor, BICC

13:30-15:55

Section 1-4: Pharmacology and Drug Discovery

Room No. 305A, 3rd Floor, BICC

13:30-17:10

Section 1-5: Neurosciences and Drug Discovery (Part I)

Room No. 305B, 3rd Floor, BICC

15:55-16:45

Section 1-8: Stem Cell and Regenerative Medicine

Room No. 305A, 3rd Floor, BICC

13:30-14:45

Section 2-5: Biochips, Microarray and Molecular Imaging for Drug Discovery

Room No. 301, 3rd Floor, BICC

15:30-17:10

Section 2-6: miRNA, siRNA/RNAi and Small RNA Technology in Drug Discovery

Room No. 301, 3rd Floor, BICC

13:30-17:30

Section 2-13: Novel Drug Delivery from New Materials to Nanotechnology (Part I)

Room No. 302, 3rd Floor, BICC

13:30-14:20

Section 3-3-1: Emerging Targets for Diabetes Drug Discovery - From Genetics, Biomarkers, Signal Transduction to Biochemical Mechanisms

Room No. 303, 3rd Floor, BICC

14:20-17:10

Section 3-3-2: Beyond Insulin Therapy - Insulin Improvement, Incretin and Anti-Insulin Resistant Therapeutics Development

Room No. 303, 3rd Floor, BICC

October 25, 2010
(Monday Morning)

08:30-12:10

Section 1-1: Oncology and Drug Discovery (Part III)

Room No. 305B, 3rd Floor, BICC

08:30-11:45

Section 1-7: Formulation in Drug Discovery

Room No. 305A, 3rd Floor, BICC

08:30-09:20

Section 2-7: Advanced Cell-based to Tissue-based Assays

Room No. 305C, 3rd Floor, BICC

10:30-12:10

Section 2-8: HPLC/GC, LC/GC-MS, Maldi-TOF and Structure Biology for Drug Discovery (Part II)

Room No. 305C, 3rd Floor, BICC

08:30-11:45

Section 3-1-2: The Cholesterol and Lipid Management New Drug Discovery

Room No. 301, 3rd Floor, BICC

08:30-10:10

Section 3-3-3: Progress in Non-insulin Antidiabetics – Targeting Type 2 Diabetes

Room No. 302, 3rd Floor, BICC

10:30-12:10

Section 3-3-4: Targeting Diabetes Related Metabolic Complications - From Foot, Eye, Inflammation, Cardiovascular, Macrovascular to Nephropathy

Room No. 302, 3rd Floor, BICC

08:30-10:10

Section 3-6: Autoimmune and Other Severe Immune Diseases

Room No. 303, 3rd Floor, BICC

08:30-12:10

Section 4-2: Computer Aided Drug Design and SAR Studies

Room No. 310, 3rd Floor, BICC

10:30-11:45

Section 6-2: Clinical Pharmacology and Efficacy Research Progress

Room No. 303, 3rd Floor, BICC

October 25, 2010
(Monday Afternoon)

13:30-15:10

Section 1-5: Neurosciences and Drug Discovery (Part II)

Room No. 305A, 3rd Floor, BICC

15:30-17:35

Section 1-6: Toxicology, Drug Safety Evaluation and Drug Discovery

Room No. 305A, 3rd Floor, BICC

13:30-16:20

Section 1-9: Microbiology, Virology and Drug Discovery

Room No. 305B, 3rd Floor, BICC

13:30-17:35

Section 2-9: Novel DMPK and ADMET Technologies

Room No. 305C, 3rd Floor, BICC

13:30-14:20

Section 2-10: Validated Animal Models in Drug Discovery

Room No. 301, 3rd Floor, BICC

15:30-17:35

Section 2-11: New Kinase Inhibitors

Room No. 301, 3rd Floor, BICC

13:30-17:10

Section 2-13: Novel Drug Delivery from New Materials to Nanotechnology (Part II)

Room No. 302, 3rd Floor, BICC

13:30-14:45

Section 3-3-5: Alternative Medicines for Anti-Diabetes Treatment - From Single Natural Products to Chinese Traditional Medicines

Room No. 303, 3rd Floor, BICC

15:30-17:35

Section 3-3-6: Drug Discovery Targeting Obesity - From Drug Targets to Novel Molecules

Room No. 303, 3rd Floor, BICC

13:30-15:10

Section 3-9-1: Anti-AIDS, Anti-Avian Flu, and Anti-H1N1 Drug Discovery

Room No. 310, 3rd Floor, BICC

15:30-17:35

Section 3-9-2: Anti-HCV Drug Discovery

Room No. 310, 3rd Floor, BICC

13:30-16:45

Section 4-3: Structure-Based Drug Design and Medicinal Chemistry

Room No. 311A, 3rd Floor, BICC

October 26, 2010
(Tuesday Morning)

08:30-10:10

Section 1-10: Clinical Medicine and Drug Discovery

Room No. 305A, 3rd Floor, BICC

08:30-11:50

Section 2-12: GPCR-based Drug Discovery

Room No. 305B, 3rd Floor, BICC

10:30-11:45

Section 2-14: Supporting Systems for Major Innovative Drugs

Room No. 305A, 3rd Floor, BICC

08:30-11:20

Section 4-4: Improving ADME/DMPK Profile, Reducing DDI/Toxicity, and Overcoming Formulation Difficulties

Room No. 305C, 3rd Floor, BICC

08:30-10:10

Section 6-3: Global Regulatory and IP Issues in Biosimilar Development

Room No. 301, 3rd Floor, BICC

10:30-11:45

Section 6-4: Opportunities and Challenges for Biosimilars

Room No. 301, 3rd Floor, BICC

08:30-11:10

Section 7-2: Major Bioactive Herb Fraction Discovery from Acting Mechanism Studies to Safety Evaluation

Room No. 302, 3rd Floor, BICC

11:20-12:10

Section 7-3: Reliable QC/QA Method and Standard Development

Room No. 302, 3rd Floor, BICC

08:30-11:20

Section 9-1: Integrated Services & Partnership for Drug Discovery

Room No. 308, 3rd Floor, BICC

08:30-12:10

Section 9-2: CRO, CMO and FTE in Chemistry & Biology

Room No. 303, 3rd Floor, BICC

08:30-11:20

Section 9-3: Outsourcing in Clinical Studies

Room No. 310, 3rd Floor, BICC

08:30-12:10

Symposium 1: Emerging Targets, Pathways, Biomarkers and Validation

Room No. 311A, 3rd Floor, BICC

08:30-11:20

Symposium 2: Advances in Other Existing Validated Cancer Drug Targets

Room No. 311B, 3rd Floor, BICC

08:30-11:45

Symposium 3: Anticancer Biotherapeutics Discovery and Development

Room No. 311C, 3rd Floor, BICC

08:30-10:55

Symposium 4: Nanomedicine and Targeted Cancer Drug Delivery System

Room No. 306, 3rd Floor, BICC

08:30-12:10

Symposium 5: Advances of Drug Discovery against Major Cancers

Room No. 312, 3rd Floor, BICC

11:20-12:20

Patch Clamp Workshop

Room No. 305C, 3rd Floor, BICC